Altre lingue Turnstone Biologics Corp.

Azioni

TSBX

US90042W1009

Tempo reale stimato Cboe BZX Altri mercati azionari 21:58:53 10/05/2024			Variaz. 5gg	Var. 1 gen.
3,025 ^USD	+5,40%		+12,50%	+20,24%

16/04	Turnstone Biologics Corp. annuncia cambiamenti nel Consiglio di Amministrazione	CI
21/03	Turnstone Biologics Corp. riporta i risultati degli utili per il quarto trimestre e l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference	08/05
Turnstone Biologics Appoints William Waddill to its Board of Directors	16/04
Turnstone Biologics Corp. Announces Board Changes	16/04
Turnstone Biologics Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	21/03
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights	21/03
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights	21/03
Turnstone Biologics to Participate in Upcoming Investor Conferences	21/02
Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.	20/02
Turnstone Biologics Corp. Announces Demise of P. Joseph Campisi, Jr., Esq, Chief Legal Officer	20/02
Certain Common Stock of Turnstone Biologics Corp. are subject to a Lock-Up Agreement Ending on 17-JAN-2024.	17/01
Certain Stock Options of Turnstone Biologics Corp. are subject to a Lock-Up Agreement Ending on 17-JAN-2024.	17/01
Turnstone Biologics Falls 11% in Premarket Activity Tuesday After Surging 42% in Previous Regular Trading Session	05/12
Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference	27/11
Turnstone Biologics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights	10/11
Top Premarket Gainers	03/11
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting	03/11
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting	03/11
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte Therapy in Solid Tumors At the 2023 Society for Immunotherapy of Cancer Annual Meeting	03/11
Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber	30/10/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Turnstone Biologics Corp.

Azioni

TSBX

US90042W1009

Altre lingue

Filtri